BBLG Earnings

Quarterly EPS
$-14.21
Q3 2024
$-1.86
Q4 2024
$-1.92
Q1 2025
$-1.33
Q2 2025
$-0.37
Q3 2025
$-0.38
Q4 2025
$-0.43
Q1 2026
$-0.43
Q2 2026
Latest RevenueN/A
Latest Net Income-773702
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.430-773702+67.7%
Q1 2026-$0.430-765988+77.6%
Q4 2025-$0.380-684643+79.6%
Q3 2025-$0.370-666737+97.4%
Q2 2025-$1.330-740519+66.9%
Q1 2025-$1.920-1017092+75.6%
Q4 2024-$1.860-1521715+94.9%
Q3 2024-$14.210-941002+51.7%
Q2 2024-$4.020-783733
Q1 2024-$7.860-865970
Q4 2023-$36.590-1549885
Q3 2023-$29.400-1919709
Bone Biologics (BBLG) — Earnings